UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000027793 |
|---|---|
| Receipt number | R000031850 |
| Scientific Title | Clot regression effects of rivaroxaban in treatment of venous thromboembolism in cancer patients. |
| Date of disclosure of the study information | 2017/06/17 |
| Last modified on | 2022/12/31 14:20:43 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/06/16 23:29:09 | ||
| 2 | Update | 2019/12/18 09:16:03 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Organization Address Address Tel |
|
| 3 | Update | 2019/12/18 09:19:18 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
| 4 | Update | 2019/12/18 09:23:21 | URL releasing protocol |
|
| 5 | Update | 2022/12/31 14:19:44 | URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 6 | Update | 2022/12/31 14:20:21 | Recruitment status |
|
| 7 | Update | 2022/12/31 14:20:43 | Publication of results |
